This book summarises the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants:: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone and venlafaxine in treating patients with MDD, dysthymia and subsyndromal depression. It also evaluates the comparative efficacy and effectiveness for maintaining remission and for treating accompanying symptoms such as anxiety, insomnia or neurovegetative symptoms..
Preface; Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression; Appendices to Antidepressants Report; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.